TecDAX | Evotec Aktie: EU will. Investition von 150 Mio EUR für zweite biopharmazeutische Produktionsanlage - hohe Förderung. Hohe Nachfrage. Sofort Gewinnbringer.
EVOTEC SE REPORTS FIRST HALF-YEAR 2020 RESULTS AND CORPORATE UPDATES
EVT 17.57 EUR - TeleTrader.com
Aktien – DE0005664809 – Evotec SE Inhaber-Aktien o.N. – Quotrix
Evotec: Live Indikation, Chart, Kurs, Statistiken, wikifolio, Social Media, Trading, Bilder (ISIN: DE0005664809) - Börse Social
Cyprotex, an Evotec Company, Expands into New UK Facility at Alderley Park — Alderley Park
EVOTEC SE : Aktie Börse Kurs | EVT | DE0005664809 | MarketScreener
Aktien – DE0005664809 – Evotec SE Inhaber-Aktien o.N. – Quotrix
Mubadala Investment Company and Novo Holdings A/S Invest € 250 M in Evotec Se | Mubadala
Evotec announces agreement with Janssen to develop immune-based therapies
EVOTEC AG AND MARS INNOVATION ANNOUNCE FIRST FUNDED PROJECT
EVOTEC : EVT Stock Price | DE0005664809 | MarketScreener
Evotec SE General Corporate Statement By Foreign Issuer (Form6) (0001654954-23-003689) - Evotec (OTC:EVOTF) - Benzinga
EVOTEC SE : Kurs Aktie Börse | 566480 | DE0005664809 | MarketScreener
Aktien – DE0005664809 – Evotec SE Inhaber-Aktien o.N. – Quotrix
Evotec Aktie | Chart | WKN 566480, ISIN DE0005664809 | aktiencheck.de
Boehringer Ingelheim, Evotec and BioMérieux Launch Aurobac, a joint venture to fight Antimicrobial Resistance – News & Updates
EVOTEC AG (DE0005664809) Assembleia Geral de Acionistas O emitente em referência anunciou a realização de uma assembleia de a
EVOTEC SE : Kurs Aktie Börse | 566480 | DE0005664809 | MarketScreener
Corporate Action Information
